MMA Asset Management’s iShares Core MSCI EAFE ETF IEFA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2M Buy
20,705
+1
+0% +$96 0.64% 39
2026
Q1
$1.87M Sell
20,704
-3,620
-15% -$338K 0.66% 36
2025
Q4
$2.18M Buy
24,324
+3,541
+17% +$313K 0.78% 33
2025
Q3
$1.81M Buy
20,783
+483
+2% +$41K 0.61% 39
2025
Q2
$1.69M Sell
20,300
-19
-0.1% -$1.51K 0.65% 35
2025
Q1
$1.54M Sell
20,319
-40
-0.2% -$2.99K 0.65% 30
2024
Q4
$1.43M Sell
20,359
-21,200
-51% -$1.56M 0.63% 30
2024
Q3
$2.95M Buy
41,559
+21,186
+104% +$1.59M 0.79% 28
2024
Q2
$1.48M Buy
20,373
+2
+0% +$147 0.69% 30
2024
Q1
$1.51M Sell
20,371
-984
-5% -$70K 0.71% 29
2023
Q4
$1.5M Sell
21,355
-25
-0.1% -$1.65K 0.79% 31
2023
Q3
$1.38M Sell
21,380
-65
-0.3% -$4.35K 0.8% 31
2023
Q2
$1.45M Buy
+21,445
New +$1.45M 0.85% 30

Other funds holding IEFA

MMA Asset Management's IEFA Position: Q2 2026 in Review

MMA Asset Management increased its iShares Core MSCI EAFE ETF (IEFA) stake by 0% in Q2 2026, buying an estimated $96 and bringing the position to 20,705 shares worth $2M. The position accounts for 0.64% of the portfolio, ranked #39.

MMA Asset Management first reported a position in IEFA in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.95M in Q3 2024. 2,454 funds tracked by Wall St. Rank hold IEFA as of Q2 2026.

  • MMA Asset Management held 20,705 shares of iShares Core MSCI EAFE ETF worth $2M as of Q2 2026.
  • MMA Asset Management bought 1 iShares Core MSCI EAFE ETF share in Q2 2026, an estimated $96.
  • iShares Core MSCI EAFE ETF made up 0.64% of MMA Asset Management's portfolio in Q2 2026, its #39 holding.
  • MMA Asset Management first reported a position in iShares Core MSCI EAFE ETF in Q2 2023 and has held it in 13 quarters since.
  • MMA Asset Management's iShares Core MSCI EAFE ETF position peaked at $2.95M in Q3 2024.
  • 2,454 funds tracked by Wall St. Rank held iShares Core MSCI EAFE ETF as of Q2 2026.

Based on MMA Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.